1238763

Takeda Pharmaceutical Company Limited — FEI 3002808311

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
April 12, 2024
Fiscal Year
2024
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Yodogawa-Ku (Japan)